Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001062993-25-003084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-18 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $11.00 | +1.36M | 31.42M | +5% | +$15.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | P | A | 1,363,636 | $11.00 | 31,424,760 | D | — | — |